Beyer DT[au] - Search Results

Year	Number of Results
2015	1
2016	3
2017	2
2018	1
2019	3
2023	0

1

Importance of Routine Bone Mineral Density Screening Prior to Elective Total Joint Replacement.

Miller AM, Beyer DT, Starring HM, Leonardi C, Bronstone AB, Dasa V. Miller AM, et al. Among authors: beyer dt. Orthopedics. 2019 Nov 1;42(6):310-312. doi: 10.3928/01477447-20191022-01. Orthopedics. 2019. PMID: 31751487 No abstract available.

2

Prognostic Factors in Typical and Atypical Pulmonary Carcinoids.

Ramirez RA, Beyer DT, Diebold AE, Voros BA, Chester MM, Wang YZ, Boudreaux JP, Woltering EA, Uhlhorn AP, Ryan P, Campeau RJ, Anthony LB. Ramirez RA, et al. Among authors: beyer dt. Ochsner J. 2017 Winter;17(4):335-340. Ochsner J. 2017. PMID: 29230118 Free PMC article.

3

The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors.

Ramirez RA, Beyer DT, Chauhan A, Boudreaux JP, Wang YZ, Woltering EA. Ramirez RA, et al. Among authors: beyer dt. Oncologist. 2016 Jun;21(6):671-5. doi: 10.1634/theoncologist.2015-0470. Epub 2016 May 25. Oncologist. 2016. PMID: 27226359 Free PMC article.

4

Plasma Neurokinin A Levels Predict Survival in Well-Differentiated Neuroendocrine Tumors of the Small Bowel.

Woltering EA, Voros BA, Thiagarajan R, Beyer DT, Ramirez RA, Wang YZ, Mamikunian G, Boudreaux JP. Woltering EA, et al. Among authors: beyer dt. Pancreas. 2018 Aug;47(7):843-848. doi: 10.1097/MPA.0000000000001092. Pancreas. 2018. PMID: 29939909

5

Plasma Pancreastatin Predicts the Outcome of Surgical Cytoreduction in Neuroendocrine Tumors of the Small Bowel.

Woltering EA, Voros BA, Beyer DT, Thiagarajan R, Ramirez RA, Mamikunian G, Boudreaux JP. Woltering EA, et al. Among authors: beyer dt. Pancreas. 2019 Mar;48(3):356-362. doi: 10.1097/MPA.0000000000001263. Pancreas. 2019. PMID: 30768573

6

Elevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the Duodenum.

Woltering EA, Beyer DT, Thiagarajan R, Ramirez RA, Wang YZ, Ricks MJ, Boudreaux JP. Woltering EA, et al. Among authors: beyer dt. J Am Coll Surg. 2016 Apr;222(4):534-42. doi: 10.1016/j.jamcollsurg.2015.12.014. Epub 2015 Dec 21. J Am Coll Surg. 2016. PMID: 26827125

7

Does the addition of adjuvant intraoperative tumor bed chemotherapy during midgut neuroendocrine tumor debulking procedures benefit patients?

Wang YZ, Chauhan A, Ramirez RA, Beyer DT, Stevens MA, Woltering EA, Boudreaux JP, Anthony L. Wang YZ, et al. Among authors: beyer dt. J Gastrointest Oncol. 2019 Oct;10(5):928-934. doi: 10.21037/jgo.2019.07.05. J Gastrointest Oncol. 2019. PMID: 31602331 Free PMC article.

8

Obturator Canal Lymph Node Metastasis from Rectal Carcinoid Tumors: Total Mesorectal Excision May Be Insufficient.

Wang YZ, Beyer DT, Hall M. Wang YZ, et al. Among authors: beyer dt. J Gastrointest Surg. 2016 Jun;20(6):1247-52. doi: 10.1007/s11605-016-3128-9. Epub 2016 Mar 21. J Gastrointest Surg. 2016. PMID: 27000128

9

Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single Institution.

Woltering EA, Voros BA, Beyer DT, Wang YZ, Thiagarajan R, Ryan P, Wright A, Ramirez RA, Ricks MJ, Boudreaux JP. Woltering EA, et al. Among authors: beyer dt. J Am Coll Surg. 2017 Apr;224(4):434-447. doi: 10.1016/j.jamcollsurg.2016.12.032. Epub 2017 Jan 11. J Am Coll Surg. 2017. PMID: 28088602

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results